Product Information

DASATINIB 100 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $24.0901 per EA under NDC 00480510456. Its NADAC has been published 54 times since Nov 5, 2025.

FDA first approved this application on Aug 27, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DASATINIB 100 MG TABLET

Dasatinib
$24.0901per EA

Strength

100 mg/1

NDC

00480510456

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DASATINIB

Approval Type

Generic (ANDA)

FDA Application

ANDA211094

FDA Approved

8/27/2025

TE Code

AB

On Market Since

9/18/2025

Pharmacological Classes

Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor
Protein Kinase Inhibitors

Price Statistics

The NADAC for DASATINIB 100 MG TABLET has been published 54 times since Nov 5, 2025, and over the history we have for it it has declined 87.4%. The table below summarizes its recorded NADAC range and movement.

Current price$24.0901 per EA
All-time high$191.7363 (Dec 10, 2025)
All-time low$24.0901 (Oct 21, 2026)
52-week high$191.7363
52-week low$24.0901
Median price$27.9731
Average price$45.8842
Largest weekly change-84.2% (Dec 17, 2025)
Weeks tracked54
Tracking sinceNov 5, 2025

Price History

1W

0.0%

1M

-8.9%

3M

-8.8%

6M

-13.9%

1Y

-87.4%

3Y

N/A

5Y

N/A

All

-87.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DASATINIB 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DASATINIB 100 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $24.0901 per EA (NDC 00480510456), effective Nov 11, 2026.

How has the price of DASATINIB 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for DASATINIB 100 MG TABLET has declined 87.4%. It has been tracked across 54 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for DASATINIB 100 MG TABLET?

Since Nov 5, 2025, the NADAC for DASATINIB 100 MG TABLET has ranged from a low of $24.0901 (Oct 21, 2026) to a high of $191.7363 (Dec 10, 2025), with a median of $27.9731 per EA.

Are there cheaper alternatives to DASATINIB 100 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DASATINIB 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DASATINIB 100 MG TABLET?

DASATINIB 100 MG TABLET (NDC 00480510456) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.